Ropes and Gray: Generate Biomedicines Enters Collaboration With Zealand Pharma to Develop Protein Therapeutics for Metabolic Diseases Up to $1.2 Billion
October 15, 2026
October 15, 2026
BOSTON, Massachusetts, Oct. 15 -- Ropes and Gray, a law firm, issued the following news:
* * *
Generate Biomedicines Enters Collaboration with Zealand Pharma to Develop Protein Therapeutics for Metabolic Diseases up to $1.2 Billion
October 14, 2026
Ropes & Gray advised Generate Biomedicines in a multi-target strategic collaboration and licensing agreement with Zealand Pharma to develop protein therapeutics for obesity and metabolic diseases . . .
* * *
Generate Biomedicines Enters Collaboration with Zealand Pharma to Develop Protein Therapeutics for Metabolic Diseases up to $1.2 Billion
October 14, 2026
Ropes & Gray advised Generate Biomedicines in a multi-target strategic collaboration and licensing agreement with Zealand Pharma to develop protein therapeutics for obesity and metabolic diseases . . .